Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent

被引:58
作者
Arai, Masayoshi [1 ]
Sobou, Mari [1 ]
Vilcheze, Catherine [2 ]
Baughn, Anthony [2 ]
Hashizume, Hiroyuki [3 ]
Pruksakorn, Patamaporn [1 ]
Ishida, Shunsuke [1 ]
Matsumoto, Makoto [3 ]
Jacobs, William R., Jr. [2 ]
Kobayashi, Motomasa [1 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
[2] Albert Einstein Coll Med, Howard Hughes Med Inst, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] Otsuka Pharmaceut Co Ltd, Microbiol Res Inst, Kawaguchi, Tokushima 7710192, Japan
关键词
halicyclamine; marine sponge; anti-Mycobacterium tuberculosis; dormant; hypoxia;
D O I
10.1016/j.bmc.2008.05.061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the course of our search for anti-microbial agents against dormant Mycobacterium tuberculosis, halicyclamine A was re-discovered as a lead for anti-tuberculosis agent from a marine sponge of Haliclona sp. on the guidance of the constructed bioassay. Halicyclamine A showed growth inhibition against Mycobacterium smegmatis, Mycobacterium bovis BCG, and M. tuberculosis H37Ra with MICs in the range of 1.0-5.0 mu g/ml under both aerobic condition and hypoxic condition inducing dormant state. The growth-inhibitory activity of halicyclamine A was bactericidal, and halicyclamine A did not exhibit cross-resistance with the currently used anti-tuberculosis drugs of isoniazid, ethambutol, rifampicin, and streptomycin. Halicyclamine A has been isolated originally as one of the active constituents inhibiting inosine 5'-monophosphate dehydrogenase (IMPDH). Then, in order to elucidate action-mechanism of halicyclamine A, we prepared IMPDH over-expressing strains of M. smegmatis. However, IMPDH was not target for halicyclamine A, because halicyclamine A showed same MIC value against the wild-type M. smegmatis and IMPDH over-expressing strains. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6732 / 6736
页数:5
相关论文
共 16 条
[1]   Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis [J].
Abate, G ;
Aseffa, A ;
Selassie, A ;
Goshu, S ;
Fekade, B ;
WoldeMeskal, D ;
Miörner, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :871-+
[2]   Tuberculosis - Metabolism and respiration in the absence of growth [J].
Boshoff, HIM ;
Barry, CE .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (01) :70-80
[3]  
CONNELL ND, 1994, METHOD CELL BIOL, V45, P107
[4]   Natural product growth inhibitors of Mycobacterium tuberculosis [J].
Copp, Brent R. ;
Pearce, A. Norrie .
NATURAL PRODUCT REPORTS, 2007, 24 (02) :278-297
[5]   The growing burden of tuberculosis - Global trends and interactions with the HIV epidemic [J].
Corbett, EL ;
Watt, CJ ;
Walker, N ;
Maher, D ;
Williams, BG ;
Raviglione, MC ;
Dye, C .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (09) :1009-1021
[6]   Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis [J].
Herbert, D ;
Paramasivan, CN ;
Venkatesan, P ;
Kubendiran, G ;
Prabhakar, R ;
Mitchison, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2296-2299
[7]   A TETRACYCLIC DIAMINE ALKALOID, HALICYCLAMINE-A, FROM THE MARINE SPONGE HALICLONA SP [J].
JASPARS, M ;
PASUPATHY, V ;
CREWS, P .
JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (12) :3253-3255
[8]   OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice [J].
Matsumoto, Makoto ;
Hashizume, Hiroyuki ;
Tomishige, Tatsuo ;
Kawasaki, Masanori ;
Tsubouchi, Hidetsugu ;
Sasaki, Hirofumi ;
Shimokawa, Yoshihiko ;
Komatsu, Makoto .
PLOS MEDICINE, 2006, 3 (11) :2131-2144
[9]   Tetradehydrohalicyclamine A and 22-hydroxyhalicyclamine A, new cytotoxic bis-piperidine alkaloids from a marine sponge Amphimedon sp. [J].
Matsunaga, S ;
Miyata, Y ;
van Soest, RWM ;
Fusetani, N .
JOURNAL OF NATURAL PRODUCTS, 2004, 67 (10) :1758-1760
[10]   The Enduring Hypoxic Response of Mycobacterium tuberculosis [J].
Rustad, Tige R. ;
Harrell, Maria I. ;
Liao, Reiling ;
Sherman, David R. .
PLOS ONE, 2008, 3 (01)